Advanced Medical Solutions Group (AMS)

Sector:

Health Care

Index:

FTSE AIM 50

193.80p
   
  • Change Today:
    -0.40p
  • 52 Week High: 258.00
  • 52 Week Low: 177.20
  • Currency: UK Pounds
  • Shares Issued: 217.41m
  • Volume: 79,906
  • Market Cap: £421.35m
  • RiskGrade: 156
  • Beta: 0.00

AMS Overview

We are a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on value for our customers and quality outcomes for patients.
Competitors: Convatec Group, Consort Medical
Registrars: Capita Registrars

Key Personnel

CEO: A Christopher (Chris) Meredith
CFO: Eddie Johnson
Chairman: Liz Shanahan
Independent Non-Executive Director: Douglas Le Fort
Senior Independent Non-Executive Director: Grahame Cook
Non-Executive Dir:

Contact Details

Address: Premier Park, 33 Road One, Winsford Industrial Estate, Winsford, Cheshire, United Kingdom, CW7 3RT
Phone: +44 (0) 1606 863500
Fax: +44 (0) 1606 863600
Website: http://www.admedsol.com

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share, FTSE AIM 50, FTSE AIM 100
ISIN: GB0004536594

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AMS Market Data

Currency UK Pounds
Share Price 193.80p
Change Today -0.40p
% Change -0.21 %
52 Week High 258.00
52 Week Low 177.20
Volume 79,906
Shares Issued 217.41m
Market Cap £421.35m
Beta 0.00
RiskGrade 156

AMS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.43% below the market average71.43% below the market average71.43% below the market average71.43% below the market average71.43% below the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average
Price Trend
46.69% below the market average46.69% below the market average46.69% below the market average46.69% below the market average46.69% below the market average
2.70% above the sector average2.70% above the sector average2.70% above the sector average2.70% above the sector average2.70% above the sector average
Income
86.93% below the market average86.93% below the market average86.93% below the market average86.93% below the market average86.93% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Growth
39.91% below the market average39.91% below the market average39.91% below the market average39.91% below the market average39.91% below the market average
72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 2
Sell 1
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AMS Dividends

  Latest Previous
  Final Interim
Ex-Div 30-May-24 28-Sep-23
Paid 21-Jun-24 27-Oct-23
Amount 1.66p 0.70p

Trades for 02-May-2024

Time Volume / Share Price
10:14 9,989 @ 192.94p
10:13 4,500 @ 192.95p
10:12 1,700 @ 193.60p
10:11 1,700 @ 192.60p
10:10 5,000 @ 192.95p

AMS Key Personnel

CEO A Christopher (Chris) Meredith
CFO Eddie Johnson
Chair Liz Shanahan

Top of Page